Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease.
Crohn’s disease
Mycobacterium avium subspecies paratuberculosis
RHB-104
clarithromycin
clinical trial
clofazimine
rifabutin
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
25 Jul 2024
25 Jul 2024
Historique:
received:
04
06
2024
revised:
10
07
2024
accepted:
17
07
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
This study, conducted between 4 October 2013, and 30 November 2018, tested the hypothesis that triple antimicrobial therapy, targeting
Identifiants
pubmed: 39199994
pii: antibiotics13080694
doi: 10.3390/antibiotics13080694
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT01951326']
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : RedHill Biopharma, Ltd., Tel Aviv, Israel
ID : N/A